» Articles » PMID: 27567280

Gemcitabine: a Game Changer in Nasopharyngeal Carcinoma

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2016 Aug 28
PMID 27567280
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage.

Yang G, Luo B, Yang Q, Chen M, Yang X, Sun J Transl Cancer Res. 2022; 9(11):6939-6954.

PMID: 35117302 PMC: 8797368. DOI: 10.21037/tcr-20-2080.


Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.

Chan S, Chau S, Chan S, Tong C, Lam K, Kwong D Cancer Control. 2021; 28:10732748211047117.

PMID: 34565216 PMC: 8642776. DOI: 10.1177/10732748211047117.


Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma.

Sun X, Wang X, Liu S, Luo D, Sun R, Liu L Front Oncol. 2020; 10:1295.

PMID: 32850404 PMC: 7425654. DOI: 10.3389/fonc.2020.01295.


Altered properties of brain white matter structural networks in patients with nasopharyngeal carcinoma after radiotherapy.

Chen Q, Lv X, Zhang S, Lin J, Song J, Cao B Brain Imaging Behav. 2020; 14(6):2745-2761.

PMID: 31900892 DOI: 10.1007/s11682-019-00224-2.


Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging.

Zhang L, Zhou H, Gu D, Tian J, Zhang B, Dong D J Cancer. 2019; 10(18):4217-4225.

PMID: 31413740 PMC: 6691694. DOI: 10.7150/jca.33345.